Familial hypercholesterolemia carrier status and CAD polygenic risk score were associated with the risk of repeat angiogram, future revascularization, and in-stent restenosis; CHIP was associated with future heart failure and all-cause mortality risk. This evidence concerns the gene STUB1 and coronary artery disorder.